Pilot Award Recipient: Ruth Kanthula, MD, MPH
Antiretroviral therapy (ART) allows HIV to be managed as a chronic condition.
Pilot Awards Recipients
The DC CFAR funds a wide array of HIV investigators in basic, clinical, and socio-behavioral science. The most recent awardees are listed below
View the archive to learn more about awards given in 2017 or earlier.
Pilot Award Recipient: Katherine Chiappinelli, PhD
The presence of a reservoir of latently infected cells has become the major hurdle for HIV eradication and its elimination is a scientific priority to cure HIV.
Pilot Award Recipient: Chul Kim, MD, MPH
People living with HIV (PLWH) are at risk for developing diverse malignancies.
Pilot Award Recipient: Thomas Heinbockel, PhD
Since marijuana is widely used and gains more social acceptability in the U.S., it is critical to understand if, and how, marijuana and cannabinoids impact HIV.
Pilot Award Recipient: Conrad Russell Cruz, MD, PhD
Although HIV infection can be controlled by daily lifelong adherence to expensive antiretroviral therapies it cannot presently be cured.
Pilot Award Recipient: Nickie Niforatos Andescavage, MD
Pregnancies complicated by HIV have significantly higher risk of fetal complications,
Pilot Award Recipient: Nicole Angotti, PhD
As anti-retroviral treatment (ART) continues to help people living with HIV (PLWH) live longer, more and more PLWH will be growing older in the years ahead.
Pilot Award Recipient: Namita Kumari, PhD
The current antiretroviral drugs can manage HIV/AIDS but they do not eradicate the virus, making life long use of ART mandatory.
Pilot Award Recipient: Rachel Robinson, PhD
Stigma, poverty, and biology put men who have sex with men (MSM) at great risk for HIV globally.
Pilot Award Recipient: Carlos E. Rodriguez-Diaz, PhD
Latinxs are at disproportionate risk for HIV infection and, within this group, gay, bisexual, and other men who have sex with men (GBMSM) are showing an alarming increase in HIV incidence.